BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CASL - Canadian Association for the Study of the Liver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CASL - Canadian Association for the Study of the Liver
X-ORIGINAL-URL:https://hepatology.ca
X-WR-CALDESC:Events for CASL - Canadian Association for the Study of the Liver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240919
DTEND;VALUE=DATE:20240922
DTSTAMP:20260421T181849
CREATED:20240218T205721Z
LAST-MODIFIED:20240218T205816Z
UID:3494-1726704000-1726963199@hepatology.ca
SUMMARY:Conference on Liver Disease in Africa (COLDA) 2024
DESCRIPTION:Co-organized by SOLDA and Academic Medical Education in close collaboration with regional societies\, COLDA 2024 aims at empowering healthcare professionals (HCPs) to diagnose\, prevent\, treat\, and achieve a cure for liver diseases for the benefit of patients in Africa. \n \nThis being the 7th COLDA\, we continue to cultivate a platform that provides a unique opportunity for clinicians\, researchers\, policymakers\, industry representatives\, and other healthcare professionals in the African region. Together with support from an international community of experts\, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context. \nWe aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches\, state-of-the-art lectures\, oral and poster abstract presentations\, roundtable discussions\, and debates with ample time for discussion. \nWe are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge\, and experience a wide spectrum of topics related to liver disease.
URL:https://hepatology.ca/event/conference-on-liver-disease-in-africa-colda-2024/
LOCATION:Cairo\, Egypt
CATEGORIES:In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240913
DTEND;VALUE=DATE:20240915
DTSTAMP:20260421T181849
CREATED:20240315T141833Z
LAST-MODIFIED:20240508T194138Z
UID:3513-1726185600-1726358399@hepatology.ca
SUMMARY:Advancing DEI in Transplantation: A Global Perspective
DESCRIPTION:Join us for the inaugural Advancing Diversity\, Equity & Inclusion in Transplantation: A Global Perspective conference\, hosted by the Ajmera Transplant Center in Toronto\, September 13 and 14. This groundbreaking event brings together International Transplant Leaders\, clinicians\, surgeons\, nurses\, researchers\, policy makers\, and representatives from academic and community-based organizations. \n \nKey Highlights: \n\nUnderstanding DEI Challenges: Explore the critical challenges faced by transplant providers and patients in achieving Diversity\, Equity\, and Inclusion (DEI) across organ groups.\nPatient-Centric Approach: Our focus centers on patients and caregivers\, ensuring their voices are heard and their needs addressed.\nNotable Speakers:\n\nNancy Ascher: A renowned transplant surgeon and advocate for equity in healthcare.\nNorah Terrault: An expert in liver transplantation and a champion for diversity and inclusion.\n\n\n\nAbstract Submission Open! Submit your abstract for poster presentation at the conference. Abstract submission deadline: May 1\, 2024. \nDon’t miss this unique opportunity to be part of a global dialogue on advancing DEI in transplantation. Learn more and register at deiintransplant.com.
URL:https://hepatology.ca/event/advancing-dei-in-transplantation-a-global-perspective/
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240605
DTEND;VALUE=DATE:20240609
DTSTAMP:20260421T181849
CREATED:20240218T203446Z
LAST-MODIFIED:20240218T203523Z
UID:3484-1717545600-1717891199@hepatology.ca
SUMMARY:EASL Congress 2024
DESCRIPTION:Welcome to EASL Congress 2024\, a gathering that unites the world of hepatology\, taking place from 5-8 June 2024 in Milan\, Italy\, as well as online. \n \nBringing together over 7\,000 professionals\, including clinicians\, researchers\, allied health professionals\, patient representatives\, and industry professionals\, the EASL Congress stands out as Europe’s largest event in this domain. \nFour days of congress full of interactivity and hands-on learning sessions from world-class faculty. Excellent opportunities for the liver community to present their research\, network and interact face-to-face with the greatest minds in hepatology.
URL:https://hepatology.ca/event/easl-congress-2024/
LOCATION:Allianz MiCo\, Milan\, Italy\, Allianz MiCo\, Milan\, Italy
CATEGORIES:In-Person,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240509T080000
DTEND;TZID=UTC:20240509T170000
DTSTAMP:20260421T181849
CREATED:20240428T160326Z
LAST-MODIFIED:20240508T194153Z
UID:3553-1715241600-1715274000@hepatology.ca
SUMMARY:Canadian Viral Hepatitis Elimination Day
DESCRIPTION:On Thursday\, May 9\, 2024\, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada\, CanHepC\, CanHepB\, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa. \n#CanHepDay24  #HepCantWait \nThank you to our many members and allies who are helping amplify our call for the federal government\, as well as each province and territory\, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. \nFIVE FEDERAL ASKS \nIn 2016\, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories\, there are five key things the federal government can do now. \n1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.\nAn updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan. \n2. Testing: Update hepatitis C screening guidelines to be evidence-based\, develop evidence-based screening guidelines for hepatitis B\, and start offering free\, voluntary STBBI testing and linkage to care for all immigrants and newcomers.\nCanada’s hepatitis C screening guidelines recommend only screening people with certain risk factors\, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all\, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis. \n3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.\nHepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment\, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.\n​\n4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.\nHepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12\, which have a vaccination rate of ~70%\, missing the 90% WHO target. \n5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.\nIn order to measure our progress in viral hepatitis elimination\, we need reliable\, fulsome data about how many people are affected. \n\n\n\n\n\n\nSocial Media Graphics for Sharing\n\n\n\n\n\n\nThese graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.\n\n \n\n\nClick on the image to save it\n \n\nClick on the image to save it
URL:https://hepatology.ca/event/canadian-viral-hepatitis-elimination-day/
LOCATION:Ottawa\, Canada
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240503
DTEND;VALUE=DATE:20240505
DTSTAMP:20260421T181849
CREATED:20240218T204323Z
LAST-MODIFIED:20240218T204323Z
UID:3488-1714694400-1714867199@hepatology.ca
SUMMARY:Innovations in SLD Think-Tank 2024
DESCRIPTION:This 2-day program will provide an interactive platform for endocrinologists\, gastroenterologist hepatologists\, primary care physicians\, and associated health care professionals (PAs\, nurses) working in the field of SLD. Outmost goal is to allow knowledge exchange on MASLD beyond the hepatology arena and among all levels of expertise. \n \nThe new format will employ the Wilton Park style in which we intend to have panel discussions around hot topics in order to generate ideas and provide insights and recommendations: \n\nBridging the Diagnostics Gap\nPrevention is the ‘Cure’ Hidden in Plain Sight\nThe Future of Treatments Now\nMaking Ready Our World Unready\nTargeting Investments for Social and Economic Returns\nthe Role of Social Media in MASLD Education\nOpen Science Session on MASLD\n\nEach of the topics will be introduced by a short lecture highlighting the issue and kick-starting the discussion. After a focused discussion among the panel members\, the discussion is opened to the audience ensuring an informal and interactive setting to discuss audience-proposed topics. \nRegister for SLD Think-Tank 2024 \nIn addition\, the SLD Think-Tank will accept abstract submissions and look forward to inviting the key contributors to take part in the relevant panel discussions. \nAbstract Deadline: Friday\, 1 March 2024 at 23:59 CET \nAbstract Submission Link: https://virology.eventsair.com/sld2024/abstracts \n \n 
URL:https://hepatology.ca/event/innovations-in-sld-think-tank-2024/
CATEGORIES:In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240411
DTEND;VALUE=DATE:20240412
DTSTAMP:20260421T181849
CREATED:20240218T203052Z
LAST-MODIFIED:20240318T174948Z
UID:3481-1712793600-1712879999@hepatology.ca
SUMMARY:Obesity Update Congress
DESCRIPTION:The inaugural Obesity Update (OU) congress is taking place on Thursday\, April 11\, 2024\, at the InterContinental Toronto Centre. Additional information about the congress can be found on the website at www.obesityupdate.ca.
URL:https://hepatology.ca/event/obesity-update-congress/
LOCATION:InterContinental Toronto Centre\, 225 Front Street West\, Toronto\, Ontario\, M5V 2X3\, Canada
CATEGORIES:In-Person,Webinar
END:VEVENT
END:VCALENDAR